| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/15/1999 | CN1228813A Gene conferring disease resistance in plants and uses thereof |
| 09/15/1999 | CN1228811A Modulators of BRCAI activity |
| 09/15/1999 | CN1228784A Nucleic acid encoding GAI gene of arabidopsis thaliana |
| 09/14/1999 | US5952547 Modified Bacillus thuringiensis genes with improved expression in plant cells, methods of production on and use |
| 09/14/1999 | US5952499 Therapeutic compound-fatty acid conjugates |
| 09/14/1999 | US5952489 Tissue-specific promoter |
| 09/14/1999 | US5952488 A nucleic acid molecule containing an androgen response element linked to a reporter gene; diagnosis and therapy for prostatic diseases and cancer |
| 09/14/1999 | US5952487 Nucleotide sequence for hybridization probes in cancer diagnosis |
| 09/14/1999 | US5952485 Procedures and materials for conferring disease resistance in plants |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952482 Production of hemoglobin having a δ-like globin |
| 09/14/1999 | US5952481 DNA encoding ubiquitin conjugating enzymes |
| 09/14/1999 | US5952479 Human arsenite-resistance protein |
| 09/14/1999 | US5952474 Fusion glycoproteins |
| 09/14/1999 | US5952473 Reagent and kit for determining isoprenylating activity and inhibition thereof |
| 09/14/1999 | US5952471 Antibody that binds to cluster w-4 polypeptide of human small cell lung carcinoma cells |
| 09/14/1999 | US5952470 Method for separating unmodified hemoglobin from cross-linked hemoglobin |
| 09/14/1999 | US5952469 Murine UCP3 polypeptides |
| 09/14/1999 | US5952468 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 09/14/1999 | US5952465 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 09/14/1999 | US5952463 Amino acid sequence of a protein which inhibits enzymes from kex2 family; development of new medicines and pesticides |
| 09/14/1999 | US5952461 Process for preparing human proinsulin |
| 09/14/1999 | US5952304 Platelet-derived growth factor analogues |
| 09/14/1999 | US5952303 A freeze-dryed artificial pulmonary surfactant comprising kl4 polypeptide and di- and monopalmitoylphosphatidylcholine; storage stability; nonhydrolyzing; reduced viscosity; homogeneity |
| 09/14/1999 | US5952302 Human therapeutic uses of BPI protein products |
| 09/14/1999 | US5952297 Monomeric insulin analog formulations |
| 09/14/1999 | US5952293 Modulating the response of cell surface receptors by administering an oligopeptide having an amino acid sequence of a portion of that receptor's extracellular domain; insulin receptors; medical diagnosis; drug screening |
| 09/14/1999 | US5952228 Isolated cytolytic T cells which are specific for complexes OF HLA- B35 molecules and the peptide PHE Pro Ser Asp Ser Trp Cys Tyr PHE, and uses thereof |
| 09/14/1999 | US5952223 Compositions for the diagnosis and treatment of Chediak-Higashi syndrome |
| 09/14/1999 | US5952221 A virion having a drug-sensitivity gene and a second gene capable of providing ancillary effects to solid tumor cells; gene therapy and antitumor agents |
| 09/14/1999 | US5952216 A mutant human papillomavirus particle where aspartic acid is replaced by glutamic acid; vaccines |
| 09/14/1999 | US5952214 Human growth-related CDC10 homolog |
| 09/14/1999 | US5952212 Anticarcinogenic agents and antidiabetic agents |
| 09/14/1999 | US5952211 Method for producing active human alanine aminotransferase |
| 09/14/1999 | US5952199 A protein that contains an immunoglobulin-like domain; antiproliferative/antitumor agents, treatment of rheumatoid arthritis, psoriasis, diabeties, glaucoma, muscular disorders and immune rejection of eye transplants |
| 09/14/1999 | US5952198 Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| 09/14/1999 | US5952197 DNA encoding the chemotactic cytokine III |
| 09/14/1999 | US5952194 Flea nucleic acid sequences and uses thereof |
| 09/14/1999 | US5952190 A nucleic acid molecule, that when expressed in transfected cells from patients, is able to complement the hypersensitivity to mitomycin c; diagnosis and screening of fanconi anemia; gene therapy |
| 09/14/1999 | US5952185 Photo-activatable biotin derivatives and their use to reduce interference in immunoassays |
| 09/14/1999 | US5952179 Screens for mutations in the anti-proliferation domain of human Bcl-2 |
| 09/14/1999 | US5952175 DNA encoding a human progesterone receptor complex p23-like protein |
| 09/14/1999 | US5952034 Increasing the digestibility of food proteins by thioredoxin reduction |
| 09/14/1999 | US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/14/1999 | US5951986 Tandem synthetic HIV-1 peptides |
| 09/14/1999 | US5951985 Tumor associated epitope |
| 09/14/1999 | US5951980 Identification, production and use of new staphylokinase derivatives with reduced immunogenicity |
| 09/14/1999 | US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33 |
| 09/14/1999 | US5951974 At least about 15%, preferably about 30%, of the interferon conjugates have a nonantigenic alkylpolyether attached to a preferential histidine residue; high activity; reacting an n-oxycarbonyloxyimide at acidic ph |
| 09/14/1999 | US5951973 Use of interleukin-4 (IL-4) to treat rheumatoid arthritis |
| 09/14/1999 | US5951972 Stabilization of somatotropins and other proteins by modification of cysteine residues |
| 09/14/1999 | CA2198125C Cytoplasmic male sterility system producing canola hybrids |
| 09/14/1999 | CA2170869C Amine-derivatized nucleosides and oligonucleosides |
| 09/14/1999 | CA2132208C Method of eliminating inhibitory/instability regions of mrna |
| 09/14/1999 | CA2086087C Growth hormone crystals and a process for production of these gh-crystals |
| 09/14/1999 | CA2079229C Ubiquitin-specific protease |
| 09/14/1999 | CA2012732C Production of modified pe40 |
| 09/14/1999 | CA1340747C Hiv-2 virus variants |
| 09/14/1999 | CA1340742C Process for chromatographically separating plasma proteins, protein concentrates produced, particularly factor viii, fibrinogene, von willebrand factor and fibronectin |
| 09/14/1999 | CA1340741C Cloned genes encoding ig-cd4 fusion protiens and the use thereof |
| 09/14/1999 | CA1340740C Co-expression in eukaryotic cells |
| 09/14/1999 | CA1340736C Method for genetically modifying a plant cell for plant gene expression |
| 09/14/1999 | CA1340735C Htlv-iii envelope peptides |
| 09/14/1999 | CA1340733C Regulatory region for heterologous gene expression in yeast |
| 09/14/1999 | CA1340732C Sv40 expression vector containing hbxag as an expression marker |
| 09/13/1999 | CA2226391A1 N-terminal peptides of sdf-1 have functional activities mediated by cxcr4 |
| 09/12/1999 | CA2231952A1 Inhibition of tumor growth |
| 09/10/1999 | WO1999045394A1 Improved method for purifying cholera toxin |
| 09/10/1999 | WO1999045392A1 Diagnostic for metastatic prostate cancer |
| 09/10/1999 | WO1999045358A2 Identification and expression of human kir5.1 |
| 09/10/1999 | WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | WO1999045132A1 Poly zinc finger proteins with improved linkers |
| 09/10/1999 | WO1999045131A1 Penicillin binding protein gene and process for producing l-glutamic acid |
| 09/10/1999 | WO1999045129A1 Method for the induction of pathogen resistance in plants |
| 09/10/1999 | WO1999045128A2 Chimeric proteins with cell-targeting specificity and apoptosis-dinducing activities |
| 09/10/1999 | WO1999045121A1 EPITOPE PEPTIDES IMMUNOGENIC AGAINST $i(STREPTOCOCCUS PNEUMONIAE) |
| 09/10/1999 | WO1999045120A2 Attenuation of bacteria: materials and methods relating thereto |
| 09/10/1999 | WO1999045119A2 Production of mycobacterial polypeptides by lactic acid bacteria |
| 09/10/1999 | WO1999045118A1 Genetic sequences conferring pathogen resistance in plants and uses therefor |
| 09/10/1999 | WO1999045117A2 Interferon, ifn-hy and uses thereof |
| 09/10/1999 | WO1999045116A2 Human homolog of a nuclear migration gene and its use |
| 09/10/1999 | WO1999045115A1 Human synapse related glycoproteins (hsrp) |
| 09/10/1999 | WO1999045114A2 Human semaphorin zsmf-7 |
| 09/10/1999 | WO1999045113A1 Smad binding elements and uses thereof |
| 09/10/1999 | WO1999045112A2 Chromosome 11-linked coronary heart disease susceptibility gene chd1 |
| 09/10/1999 | WO1999045111A1 Lectomedin materials and methods |
| 09/10/1999 | WO1999045110A1 V-like domain binding molecules |
| 09/10/1999 | WO1999045109A1 Animal model with disrupted fgf-9 gene |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045101A1 RESISTANCE IN PLANTS TO INFECTION BY ssDNA VIRUS USING INOVIRIDAE VIRUS ssDNA-BINDING PROTEIN, COMPOSITIONS AND METHODS OF USE |
| 09/10/1999 | WO1999045098A2 Delivery or proteins into eukaryotic cells with recombinant yersinia |
| 09/10/1999 | WO1999045031A2 Cd147 binding molecules as therapeutics |
| 09/10/1999 | WO1999045030A1 Human g-protein coupled receptor (gpr25) |
| 09/10/1999 | WO1999045028A1 Monoclonal antibodies esm-1 protein specific, and use of said antibodies for detecting esm-1 protein |
| 09/10/1999 | WO1999045026A1 Method for increasing the serum half-life of a biologically active molecule |
| 09/10/1999 | WO1999045021A1 Cell cycle regulated genes |
| 09/10/1999 | WO1999045019A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/10/1999 | WO1999044645A1 Compositions and methods of treating tumors |
| 09/10/1999 | WO1999044628A1 Conjugates useful in the treatment of prostate cancer |
| 09/10/1999 | WO1999044626A1 Suppressors of death domains |